Oppenheimer Starts Varex Imaging (VREX) at Outperform

Oppenheimer analyst Suraj Kalia initiates coverage on Varex Imaging (NASDAQ: VREX) with a Outperform rating and a price target of $40.00.

The analyst commented, "We are initiating coverage of Varex Imaging with an Outperform rating and $40 PT. Varex is a leading supplier of x-ray imaging components to the medical and industrial segments, boasting blue-chip clients like GE, Philips, Medtronic, Varian, Elekta, Toshiba, ViewRay, etc. Our constructive stance and PT (~2x forward P/S, a 60% discount to the broader medtech universe) reflect our assessment of Varex's value proposition, combined with a critical assessment of short-term headwinds and long-term tailwinds."

For an analyst ratings summary and ratings history on Varex Imaging click here. For more ratings news on Varex Imaging click here.

Shares of Varex Imaging closed at $28.72 yesterday.

You May Also Be Interested In

• BofA Securities Resumes American Eagle Outfitters (AEO) at Underperform
• B.Riley Downgrades Varex Imaging (VREX) to Neutral
• McGraw Hill (MH) PT Raised to $15 at UBS